 | • レポートコード：GIR-2104Z00952 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗体産生のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗体産生の種類別市場規模（ポリクローナル抗体、モノクローナル抗体、マウス、キメラ、ヒト化）、用途別市場規模（製薬・バイオテクノロジー企業、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗体産生の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Thermo Fisher Scientific, Inc.、GE Healthcare、Sartorius AG、Merck KGaA、Eppendorf AG、Cellab GmbH、Pall Corp.、INTEGRA Biosciences AG、FiberCell Systems Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ポリクローナル抗体、モノクローナル抗体、マウス、キメラ、ヒト化 ・用途別分析2016年-2026年：製薬・バイオテクノロジー企業、研究所、その他 ・抗体産生の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗体産生のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗体産生のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗体産生の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗体産生の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Antibody Production market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Antibody Production size is estimated to be xx million in 2020 from USD 8727.5 million in 2019, with a change of XX% between 2019 and 2020. The global Antibody Production market size is expected to grow at a CAGR of 6.7% for the next five years.
Market segmentation
Antibody Production market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Polyclonal antibody
Monoclonal antibody
Murine
Chimeric
Humanized
Market segment by Application can be divided into
Pharmaceutical and biotechnology companies
Research laboratories
Others
The key market players for global Antibody Production market are listed below:
Thermo Fisher Scientific, Inc.
GE Healthcare
Sartorius AG
Merck KGaA
Eppendorf AG
Cellab GmbH
Pall Corp.
INTEGRA Biosciences AG
FiberCell Systems Inc.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Antibody Production Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antibody Production Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Polyclonal antibody
1.2.3 Monoclonal antibody
1.2.4 Murine
1.2.5 Chimeric
1.2.6 Humanized
1.3 Market Analysis by Application
1.3.1 Overview: Global Antibody Production Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pharmaceutical and biotechnology companies
1.3.3 Research laboratories
1.3.4 Others
1.4 Global Antibody Production Market Size & Forecast
1.4.1 Global Antibody Production Sales in Value (2016-2026))
1.4.2 Global Antibody Production Sales in Volume (2016-2026)
1.4.3 Global Antibody Production Price by Type (2016-2026) & (USD/MT)
1.5 Global Antibody Production Production Capacity Analysis
1.5.1 Global Antibody Production Total Production Capacity (2016-2026)
1.5.2 Global Antibody Production Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antibody Production Market Drivers
1.6.2 Antibody Production Market Restraints
1.6.3 Antibody Production Trends Analysis
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific, Inc.
2.1.1 Thermo Fisher Scientific, Inc. Details
2.1.2 Thermo Fisher Scientific, Inc. Major Business
2.1.3 Thermo Fisher Scientific, Inc. Antibody Production Product and Services
2.1.4 Thermo Fisher Scientific, Inc. Antibody Production Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare Antibody Production Product and Services
2.2.4 GE Healthcare Antibody Production Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Sartorius AG
2.3.1 Sartorius AG Details
2.3.2 Sartorius AG Major Business
2.3.3 Sartorius AG Antibody Production Product and Services
2.3.4 Sartorius AG Antibody Production Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Merck KGaA
2.4.1 Merck KGaA Details
2.4.2 Merck KGaA Major Business
2.4.3 Merck KGaA Antibody Production Product and Services
2.4.4 Merck KGaA Antibody Production Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Eppendorf AG
2.5.1 Eppendorf AG Details
2.5.2 Eppendorf AG Major Business
2.5.3 Eppendorf AG Antibody Production Product and Services
2.5.4 Eppendorf AG Antibody Production Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Cellab GmbH
2.6.1 Cellab GmbH Details
2.6.2 Cellab GmbH Major Business
2.6.3 Cellab GmbH Antibody Production Product and Services
2.6.4 Cellab GmbH Antibody Production Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Pall Corp.
2.7.1 Pall Corp. Details
2.7.2 Pall Corp. Major Business
2.7.3 Pall Corp. Antibody Production Product and Services
2.7.4 Pall Corp. Antibody Production Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 INTEGRA Biosciences AG
2.8.1 INTEGRA Biosciences AG Details
2.8.2 INTEGRA Biosciences AG Major Business
2.8.3 INTEGRA Biosciences AG Antibody Production Product and Services
2.8.4 INTEGRA Biosciences AG Antibody Production Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 FiberCell Systems Inc.
2.9.1 FiberCell Systems Inc. Details
2.9.2 FiberCell Systems Inc. Major Business
2.9.3 FiberCell Systems Inc. Antibody Production Product and Services
2.9.4 FiberCell Systems Inc. Antibody Production Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Antibody Production Sales by Manufacturer
3.1 Global Antibody Production Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Antibody Production Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Antibody Production
3.4 Market Concentration Rate
3.4.1 Top 3 Antibody Production Manufacturer Market Share
3.4.2 Top 6 Antibody Production Manufacturer Market Share
3.5 Global Antibody Production Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Antibody Production Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antibody Production Market Size by Region
4.1.1 Global Antibody Production Sales in Volume by Region (2016-2026)
4.1.2 Global Antibody Production Revenue by Region (2016-2026)
4.2 North America Antibody Production Revenue (2016-2026)
4.3 Europe Antibody Production Revenue (2016-2026)
4.4 Asia-Pacific Antibody Production Revenue (2016-2026)
4.5 South America Antibody Production Revenue (2016-2026)
4.6 Middle East and Africa Antibody Production Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Antibody Production Sales in Volume by Type (2016-2026)
5.2 Global Antibody Production Revenue by Type (2016-2026)
5.3 Global Antibody Production Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Antibody Production Sales in Volume by Application (2016-2026)
6.2 Global Antibody Production Revenue by Application (2016-2026)
6.3 Global Antibody Production Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Antibody Production Sales by Type (2016-2026)
7.2 North America Antibody Production Sales by Application (2016-2026)
7.3 North America Antibody Production Market Size by Country
7.3.1 North America Antibody Production Sales in Volume by Country (2016-2026)
7.3.2 North America Antibody Production Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Antibody Production Sales by Type (2016-2026)
8.2 Europe Antibody Production Sales by Application (2016-2026)
8.3 Europe Antibody Production Market Size by Country
8.3.1 Europe Antibody Production Sales in Volume by Country (2016-2026)
8.3.2 Europe Antibody Production Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Antibody Production Sales by Type (2016-2026)
9.2 Asia-Pacific Antibody Production Sales by Application (2016-2026)
9.3 Asia-Pacific Antibody Production Market Size by Region
9.3.1 Asia-Pacific Antibody Production Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Antibody Production Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Antibody Production Sales by Type (2016-2026)
10.2 South America Antibody Production Sales by Application (2016-2026)
10.3 South America Antibody Production Market Size by Country
10.3.1 South America Antibody Production Sales in Volume by Country (2016-2026)
10.3.2 South America Antibody Production Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antibody Production Sales by Type (2016-2026)
11.2 Middle East & Africa Antibody Production Sales by Application (2016-2026)
11.3 Middle East & Africa Antibody Production Market Size by Country
11.3.1 Middle East & Africa Antibody Production Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Antibody Production Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Antibody Production Typical Distributors
12.3 Antibody Production Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Antibody Production Revenue by Type, (USD Million), 2021-2026
Table 2. Global Antibody Production Revenue by Application, (USD Million), 2021-2026
Table 3. Thermo Fisher Scientific, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Thermo Fisher Scientific, Inc. Major Business
Table 5. Thermo Fisher Scientific, Inc. Antibody Production Product and Services
Table 6. Thermo Fisher Scientific, Inc. Antibody Production Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 8. GE Healthcare Major Business
Table 9. GE Healthcare Antibody Production Product and Services
Table 10. GE Healthcare Antibody Production Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sartorius AG Basic Information, Manufacturing Base and Competitors
Table 12. Sartorius AG Major Business
Table 13. Sartorius AG Antibody Production Product and Services
Table 14. Sartorius AG Antibody Production Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 16. Merck KGaA Major Business
Table 17. Merck KGaA Antibody Production Product and Services
Table 18. Merck KGaA Antibody Production Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Eppendorf AG Basic Information, Manufacturing Base and Competitors
Table 20. Eppendorf AG Major Business
Table 21. Eppendorf AG Antibody Production Product and Services
Table 22. Eppendorf AG Antibody Production Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Cellab GmbH Basic Information, Manufacturing Base and Competitors
Table 24. Cellab GmbH Major Business
Table 25. Cellab GmbH Antibody Production Product and Services
Table 26. Cellab GmbH Antibody Production Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pall Corp. Basic Information, Manufacturing Base and Competitors
Table 28. Pall Corp. Major Business
Table 29. Pall Corp. Antibody Production Product and Services
Table 30. Pall Corp. Antibody Production Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. INTEGRA Biosciences AG Basic Information, Manufacturing Base and Competitors
Table 32. INTEGRA Biosciences AG Major Business
Table 33. INTEGRA Biosciences AG Antibody Production Product and Services
Table 34. INTEGRA Biosciences AG Antibody Production Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. FiberCell Systems Inc. Basic Information, Manufacturing Base and Competitors
Table 36. FiberCell Systems Inc. Major Business
Table 37. FiberCell Systems Inc. Antibody Production Product and Services
Table 38. FiberCell Systems Inc. Antibody Production Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Antibody Production Sales by Manufacturer (2019-2021e) & (K MT)
Table 40. Global Antibody Production Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Antibody Production, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Antibody Production Production Capacity by Company, (K MT): 2020 VS 2021
Table 43. Head Office and Antibody Production Production Site of Key Manufacturer
Table 44. Global Antibody Production Sales by Region (2016-2021e) & (K MT)
Table 45. Global Antibody Production Sales by Region (2021-2026) & (K MT)
Table 46. Global Antibody Production Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Antibody Production Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Antibody Production Sales by Type (2016-2021e) & (K MT)
Table 49. Global Antibody Production Sales by Type (2021-2026) & (K MT)
Table 50. Global Antibody Production Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Antibody Production Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Antibody Production Price by Type (2016-2021e) & (USD/MT)
Table 53. Global Antibody Production Price by Type (2021-2026) & (USD/MT)
Table 54. Global Antibody Production Sales by Application (2016-2021e) & (K MT)
Table 55. Global Antibody Production Sales by Application (2021-2026) & (K MT)
Table 56. Global Antibody Production Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Antibody Production Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Antibody Production Price by Application (2016-2021e) & (USD/MT)
Table 59. Global Antibody Production Price by Application (2021-2026) & (USD/MT)
Table 60. North America Antibody Production Sales by Country (2016-2021e) & (K MT)
Table 61. North America Antibody Production Sales by Country (2021-2026) & (K MT)
Table 62. North America Antibody Production Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Antibody Production Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Antibody Production Sales by Type (2016-2021e) & (K MT)
Table 65. North America Antibody Production Sales by Type (2021-2026) & (K MT)
Table 66. North America Antibody Production Sales by Application (2016-2021e) & (K MT)
Table 67. North America Antibody Production Sales by Application (2021-2026) & (K MT)
Table 68. Europe Antibody Production Sales by Country (2016-2021e) & (K MT)
Table 69. Europe Antibody Production Sales by Country (2021-2026) & (K MT)
Table 70. Europe Antibody Production Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Antibody Production Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Antibody Production Sales by Type (2016-2021e) & (K MT)
Table 73. Europe Antibody Production Sales by Type (2021-2026) & (K MT)
Table 74. Europe Antibody Production Sales by Application (2016-2021e) & (K MT)
Table 75. Europe Antibody Production Sales by Application (2021-2026) & (K MT)
Table 76. Asia-Pacific Antibody Production Sales by Region (2016-2021e) & (K MT)
Table 77. Asia-Pacific Antibody Production Sales by Region (2021-2026) & (K MT)
Table 78. Asia-Pacific Antibody Production Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Antibody Production Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Antibody Production Sales by Type (2016-2021e) & (K MT)
Table 81. Asia-Pacific Antibody Production Sales by Type (2021-2026) & (K MT)
Table 82. Asia-Pacific Antibody Production Sales by Application (2016-2021e) & (K MT)
Table 83. Asia-Pacific Antibody Production Sales by Application (2021-2026) & (K MT)
Table 84. South America Antibody Production Sales by Country (2016-2021e) & (K MT)
Table 85. South America Antibody Production Sales by Country (2021-2026) & (K MT)
Table 86. South America Antibody Production Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Antibody Production Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Antibody Production Sales by Type (2016-2021e) & (K MT)
Table 89. South America Antibody Production Sales by Type (2021-2026) & (K MT)
Table 90. South America Antibody Production Sales by Application (2016-2021e) & (K MT)
Table 91. South America Antibody Production Sales by Application (2021-2026) & (K MT)
Table 92. Middle East & Africa Antibody Production Sales by Country (2016-2021e) & (K MT)
Table 93. Middle East & Africa Antibody Production Sales by Country (2021-2026) & (K MT)
Table 94. Middle East & Africa Antibody Production Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Antibody Production Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Antibody Production Sales by Type (2016-2021e) & (K MT)
Table 97. Middle East & Africa Antibody Production Sales by Type (2021-2026) & (K MT)
Table 98. Middle East & Africa Antibody Production Sales by Application (2016-2021e) & (K MT)
Table 99. Middle East & Africa Antibody Production Sales by Application (2021-2026) & (K MT)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Antibody Production Typical Distributors
Table 103. Antibody Production Typical Customers
List of Figures
Figure 1. Antibody Production Picture
Figure 2. Global Antibody Production Sales Market Share by Type in 2020
Figure 3. Polyclonal antibody
Figure 4. Monoclonal antibody
Figure 5. Murine
Figure 6. Chimeric
Figure 7. Humanized
Figure 8. Global Antibody Production Sales Market Share by Application in 2020
Figure 9. Pharmaceutical and biotechnology companies
Figure 10. Research laboratories
Figure 11. Others
Figure 12. Global Antibody Production Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 13. Global Antibody Production Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Antibody Production Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Antibody Production Sales (2016-2026) & (K MT)
Figure 34. Global Antibody Production Production Capacity (2016-2026) & (K MT)
Figure 35. Global Antibody Production Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Antibody Production Market Drivers
Figure 37. Antibody Production Market Restraints
Figure 38. Antibody Production Market Trends
Figure 39. Global Antibody Production Sales Market Share by Manufacturer in 2020
Figure 40. Global Antibody Production Revenue Market Share by Manufacturer in 2020
Figure 41. Antibody Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Antibody Production Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Antibody Production Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Antibody Production Sales Market Share by Region (2016-2026)
Figure 45. Global Antibody Production Revenue Market Share by Region (2016-2026)
Figure 46. North America Antibody Production Revenue (2016-2026) & (USD Million)
Figure 47. Europe Antibody Production Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Antibody Production Revenue (2016-2026) & (USD Million)
Figure 49. South America Antibody Production Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Antibody Production Revenue (2016-2026) & (USD Million)
Figure 51. Global Antibody Production Sales Market Share by Type (2016-2026)
Figure 52. Global Antibody Production Revenue Market Share by Type (2016-2026)
Figure 53. Global Antibody Production Price by Type (2016-2026) & (USD/MT)
Figure 54. Global Antibody Production Sales Market Share by Application (2016-2026)
Figure 55. Global Antibody Production Revenue Market Share by Application (2016-2026)
Figure 56. Global Antibody Production Price by Application (2016-2026) & (USD/MT)
Figure 57. North America Antibody Production Sales Market Share by Country (2016-2026)
Figure 58. North America Antibody Production Revenue Market Share by Country (2016-2026)
Figure 59. North America Antibody Production Sales Market Share by Type (2016-2026)
Figure 60. North America Antibody Production Sales Market Share by Application (2016-2026)
Figure 61. Europe Antibody Production Sales Market Share by Country (2016-2026)
Figure 62. Europe Antibody Production Revenue Market Share by Country (2016-2026)
Figure 63. Europe Antibody Production Sales Market Share by Type (2016-2026)
Figure 64. Europe Antibody Production Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Antibody Production Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Antibody Production Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Antibody Production Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Antibody Production Sales Market Share by Application (2016-2026)
Figure 69. South America Antibody Production Sales Market Share by Country (2016-2026)
Figure 70. South America Antibody Production Revenue Market Share by Country (2016-2026)
Figure 71. South America Antibody Production Sales Market Share by Type (2016-2026)
Figure 72. South America Antibody Production Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Antibody Production Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Antibody Production Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Antibody Production Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Antibody Production Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界のモノクローナル抗体療法市場規模・現状・予測（2021年-2027年） Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…- 世界のヒト化抗体市場規模・現状・予測（2021年-2027年） Humanized antibodies mainly refer to antibodies re-expressed by gene cloning and DNA recombination technology of mouse monoclonal antibodies, most of the amino acid sequences of which are replaced by human sequences, and reducing the Its heterogeneity is beneficial to the human body.The constant reg…
- 世界のモノクローナル抗体治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Monoclonal Antibody Therapeutics Market The global Monoclonal Antibody Therapeutics market size is projected to reach US$ 178100 million by 2026, from US$ 109280 million in 2019, at a CAGR of 7.1% during 2021-2026. With industry-standard accuracy in analysis and …
- 世界のモノクローナル抗体サービス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Monoclonal Antibody Service Market The global Monoclonal Antibody Service market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界のモノクローナル抗体サービス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Monoclonal Antibody Service Market The global Monoclonal Antibody Service market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…